To evaluate the effect of the introduction of digital mammography on the recall rate, detection rate, false-positive rate, and rates of invasive procedures in a cohort of women from four population-based breast cancer screening programs in Spain.
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The study was approved by the ethics committee, and informed consent was not required. The selection criterion for inclusion in the screening programs was having completed at least one screening round performed with DM by December 2007. A total of 19 032 screening mammograms were included in a previous study ( 9 ) . All programs are based on the European guidelines for quality assurance in screening mammography ( 13 ) , and their results meet the required standards. Women in the target population receive information about screening and are invited to undergo mammography with a 2-year interval between screening rounds.
All radiology units began screening activities between 1996 and 1998 by using screen-fi lm radiographic technology and switched to full-fi eld DM between September 2004 (one program) and January 2005 (three programs). Two programs used a 2000D unit (Senographe; GE Medical Systems, Milwaukee, Wis) and two used a DM 1000 unit (Agfa; Lorad, Danbury, Conn).
By December 2007, one radiology unit had fi nished the fourth screening round, two units were at the fi fth screening round, and two units were at the sixth screening round. The age at screening was 50-69 years in three programs and 45-69 years in one program. All Information on the effects of DM within operational population-based breast cancer screenings programs is still scarce.
Some authors have started to report results of the impact of DM in a population-based screening practice (6) (7) (8) (9) , but the results on recall rate are controversial. One of the main limitations of these studies was the relatively low number of screening tests performed with DM and the fact that most were performed within a single program and no adjustments were made to control for other risk factors affecting the recall rate.
Two of the main disadvantages of breast cancer screening are the recall rate and false-positive results, which, although intrinsic parts of the program, may lead to additional (sometimes invasive) tests, thus increasing costs and provoking anxiety in women before malignancy is ruled out ( 10 ) . Therefore, determining whether DM increases or reduces recall rates and false-positive results, with similar diagnostic performance to that of SFM, is of great importance, especially at a time when the risks and benefi ts of screening mammography are being debated ( 11, 12 ) .
The aim of this study was to evaluate the effect of the introduction of DM on the recall rate, detection rate, falsepositive rate, and rates of invasive procedures in a cohort of women from four population-based breast cancer screening programs in Spain.
Materials and Methods

Setting
Five radiology units from four different population-based breast cancer screen ing programs in Spain were enrolled, covering a population of 1 300 000 inhabitants.
D
igital technology is increasingly used for both diagnostic and screening mammography ( 1 ) . Diagnostic performance of digital mammography (DM) is generally accepted to be at least equal to that of conventional screen-fi lm mammography (SFM). However, studies comparing DM and SFM in screening mammography have shown divergent results, mainly in the recall rates, partly due to differences in study designs and several other factors. A recent review by Skaane ( 2 ) concluded that DM has an overall higher cancer detection rate than does SFM in screening mammography, achieved at the cost of a higher recall rate. However, a metaanalysis by Vinnicombe et al ( 3 ) , including six of the seven studies analyzed in the review by Skaane, could not calculate pooled estimates for recall rates because they varied greatly among studies. The latest update of breast cancer screening by the U.S. Preventive Services Task Force ( 4 ) for the recent recommendation statement ( 5 ) included information on the benefi ts and harms of breast cancer screening based predominantly on studies of SFM but not on studies of DM.
Implications for Patient Care
DM with soft-copy reading could n prevent a number of women from recall and false-positive results without affecting the cancer detection rate.
The lower false-positive risk with n DM should be taken into account when balancing the risks and benefi ts of breast cancer screening.
Advances in Knowledge
The recall rate, false-positive n results overall, and false-positive fi ndings resulting in an invasive procedure were lower with digital mammography (DM) with softcopy reading (6.2%, 5,7%, and 0.74%, respectively) than with screen-fi lm mammography (8.1%, 7.6%, and 1.9%, respectively) in four population-based screening programs in Spain ( P , .001).
The lower false-positive risk n re mained after adjustment was made for women's screening mammogram, age at screening, radiologic unit screening round, screening program characteristics , and time trends.
No differences were observed in n the cancer detection rate between screen-fi lm and DM in women younger than 50 years of age or in the fi rst or successive screening rounds. Multivariate logistic regression models were constructed to evaluate the effect of the mammographic technology used (SFM and DM) on the false-positive results and the odds ratio (OR) of cancer detection, adjusted according to women's screening round (women who were undergoing their fi rst to sixth screening round; the second to sixth screening rounds for each woman were included in the group of successive screening rounds), age at screening, the screening round of the radiology unit, and the screening program. The number of views and the reading method were not included because they are variable and highly associated with specifi c programs.
False-positive models included the screening program in which mammography was performed as a random effect, since we were concerned about the clustered structure of the data. To account for repeated measures in the same participant, we also included each woman's participations as a random effect (compound symmetry structure) ( 14 ) . However, no random effects were included in the cancer detection models since no effect for the screening program was found (the covariance matrix for program effects was null), and repeated measures in the same woman were considered independent observations (cancer detection is always conditional on not having had previous breast cancer).
To exclude potential confounding factors due to time trends, we divided the screening history in each radiology unit into six consecutive time intervals. The SFM period was divided into four intervals with an equal number of mammograms (quartiles). Similarly, each DM period was divided into two equal intervals by using the median date of mammography. In each radiology unit , the fi rst digital period was preceded by four analog periods. Thus, we obtained a combined time/technique variable, which we called "SFM/FFDM periods." The logistic regression models were replicated by using the variable of the combined "SFM/FFDM periods" instead of the mammographic technique and radiology unit screening round independently to control (for which follow-up at 2 years is recommended) or positive results (abnormal fi ndings requiring a recall for immediate further assessment to exclude malignancy). As proposed in the European guidelines ( 13 ), the program did not include an early recall as a direct result of the fi ndings from screening mammogram, that is, recommendation for a woman to undergo a short-term rescreening at an interval shorter than the program's routine screening round length (2 years) without any other additional investigation. A positive result was considered a true-positive result if, after further assessments, breast cancer was found (ductal carcinoma in situ or invasive cancer). Otherwise, the result was considered to be false-positive. Further assessments could include both noninvasive (additional mammography, ultrasonography, magnetic resonance imaging) and invasive procedures (fi neneedle aspiration cytologic analysis, coreneedle biopsy, and open biopsy). Falsepositive results were classifi ed into two types: false-positive overall (noninvasive and/or invasive, further assessment was performed) and false-positive resulting in an invasive procedure (at least one invasive, further assessment was performed). Early recalls were not considered as false-positive results if they did not involve further procedures that resulted in a noncancer. Only repeat screenings achieving suffi cient technical quality were included as the screening examination.
Statistical Analysis
The recall rate was defi ned as the percentage of screened women requiring at least one further assessment after a positive mammogram. The detection rate was defi ned as the percentage of screened women with a true-positive result, that is, a fi nal diagnosis of breast cancer (invasive cancer and ductal carcinoma in situ). The positive predictive value (PPV) of screening was defi ned as the fraction of recall examinations leading to a diagnosis of breast cancer.
The recall rate, overall false-positive results, false-positive fi ndings resulting in an invasive procedure, the breast cancer rate, and the PPV were computed for each group by using simple proportions programs obtained two views (mediolateral oblique and craniocaudal) from 2007 onward. Before this date, a single view was obtained for subsequent screenings in one program. Reading methods were single reading in one program, double reading with consensus in two programs, and double reading with arbitration in one program. The different reading methods were used equally within each program before and after the introduction of the digital method. None of the programs used a computer-aided detection system.
Twenty-six radiologists participated in the study. Experience in mammogram reading varied, but most radiologists were involved in the programs from their beginning and all had read a minimum number of mammograms (between 3000 and 5000) before entering the screening program, as recommended by the European guidelines ( 13 ) . The fi nal database covered information on the women's age, mammographic technology (analog or digital), and further assessments after a positive screening mammogram. A defi nitive diagnosis of breast cancer was always confi rmed histopathologically. No information about previous mammograms was provided at reading at the fi rst screening round. Previous mammograms obtained with SFM were not digitized. All information was collected at each woman's attendance, and no major changes took place in the reading protocol when DM was introduced.
Study Population
This study included women participating in at least one screening in any of the four screening programs. Mammograms obtained with DM during the fi rst 3 months after the technology was changed, which could be considered a learning period, were excluded and only mammograms with soft-copy reading were included in the analysis. A total of 242 838 screening mammograms from 103 613 women were included in the analysis, of which 171 191 were screen fi lm (SFM group) and 71 647 were digital (DM group).
Screening Results
Two possible outcomes of a screening test were considered: normal fi ndings
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The false-positive risk for DM periods was signifi cantly lower than that for the fi rst SFM period (fi rst DM period: OR = 0.81, 95% CI: 0.76, 0.86; second DM period: OR = 0.79, 95% CI: 0.74, 0.84; Fig 2 ) . The risk of a false-positive fi nding resulting in an invasive procedure ( Fig 3 ) was also lower in the DM periods than in the fi rst SFM period (fi rst DM period: OR = 0.61, 95% CI: 0.53, 0.71; second DM period: OR = 0.50, 95% CI: 0.42, 0.59).
Discussion
This study retrospectively analyzed a cohort of women from four breast cancer screening programs in which FSM and/or DM were used between 1996 and 2007. The results of these analyses show that while cancer detection did not differ in women screened with SFM or DM, the recall rate and falsepositive risk were lower with DM than with SFM after adjustment was made for women's screening mammogram, radiology unit screening round, age at screening, and time trends.
These results seem to contradict the fi nal conclusion of a review by Skaane ( 2 ) . One of the limitations of that review, as well as of the meta-analysis by Vinnicombe et al ( 3 ) , is that they included few studies performed in real population-based breast cancer screening conditions and the studies included differed fairly widely in their characteristics. Because DM was introduced in the period 2000-2005, the number of DMs in all of the studies was relatively small, being fewer than 20 000 in all studies ( 3,6,7 ) except one, which included 26 000 DMs ( 8 ) . One of the studies ( 3 ) used hardcopy reading, while others used softcopy reading ( 6,7 ). Moreover, only two studies included initial and successive screening mammograms, and only one ( 3 ) assessed the interaction between the screening round and the technique. A learning period after the introduction of the digital technique was only excluded in one study ( 8 ) . Only one of the studies performed a multivariate analysis ( 3 ), allowing simultaneous control of distinct variables that could have had an effect on the detection rate, recall group for both the fi rst (13.2% vs 17.4, P = .005) and successive (13.5% vs 18.8%, P , .001) screening rounds. The PPV was 5.6% (770 cancers in 13 860 recalled women) for SFM and 7% (310 of 4420) for DM.
The cancer detection risk was 4.8% higher with SFM than with DM (OR = 1.05; 95% confi dence interval [CI]: 0.87, 1.29; Table 2 ). The fi rst screening round had an increased risk of cancer detection (OR = 1.57; 95% CI: 1.23, 2.02) compared with the fourth or subsequent rounds. The cancer detection risk increased with age. The estimated OR in the group aged 45-49 years was 0.44 (95% CI: 0.32, 0.59) compared with the group aged 65-69 years. No signifi cant differences were found between the groups aged 60-64 years and 65-69 years.
A signifi cantly increased risk of a false-positive result overall was observed for SFM compared with DM (OR = 1.32; 95% CI: 1.25, 1.40; Table 3 ). The fi rst, second, and third screening mammograms also had an increased risk of a false-positive result related to the fourth and subsequent screening s (OR = 2.95; 95% CI: 2.74, 3.17; fi rst screening). Similarly, younger age groups were at higher risk of a false-positive result than the group aged 65-69 years (OR = 1.59; 95% CI: 1.48, 1.72; group aged 45-49 years). The risk of a false-positive fi nding resulting in an invasive procedure was higher for SFM than for DM (OR = 1.64; 95% CI: 1.43, 1.87) in the fi rst screening round than in successive screening rounds (OR = 3.49; 95% CI: 2.95, 4.1) and in younger age groups (OR = 1.42; 95% CI: 1.20, 1.70; group aged 45-49 years).
The second and third SFM periods had a signifi cantly lower risk of cancer detection compared with the fi rst SFM period (second SFM period: OR = 0.73, 95% CI: 0.59, 0.91; third SFM period: OR = 0.78, 95% CI: 0.63, 0.97; Fig 1 ) . The fourth SFM period and the fi rst and second DM periods had lower cancer detection ORs compared with the fi rst SFM period , although this difference was not statistically signifi cant, and the OR for the second DM period was slightly higher than that for the previous period (OR = 0.87 and 0.82, respectively).
for possible errors in the estimations due to a high correlation between them.
All calculations were performed by using software (SAS system for Windows, version 9.1.3; SAS Institute, Cary, NC). The logistic procedure was used for the cancer detection model and the Glimmix software (version 9.1; SAS Institute) was used for the false-positive model. An a level was set at .05, and all tests were two tailed.
Results
A total of 242 838 screening mammograms obtained in 103 613 women were included in the analysis. The overall recall rate was higher in the SFM group than in the DM group (13 860 Table 1 ). The recall rate at fi rst screening round was higher in the SFM group than in the DM group (12.1% and 11.7%, respectively; P = .091), as well as at successive screening rounds (5.0% in SFM and 4.6% in DM group; P , .001). Early recalls were also higher in the SFM group than in the DM group (0.78% and 0.25%, respectively; P , .001). False-positive results, in agreement with recall rates, were higher in the SFM group than in the DM group (7.6% vs 5.7%, P , .001), but differences were not statistically signifi cant at the fi rst screening round (11.6% vs 11.1%; P = .078). Falsepositive fi ndings resulting in an invasive procedure were signifi cantly higher in the SFM group than in the DM group for both the fi rst (3.0% vs 1.7%, respectively; P , .001) and successive screening rounds (1% vs 0.45%, respectively; P , .001). In total, 1080 cancers were detected, 770 in the SFM group and 310 in the DM group, representing a cancer detection rate of 0.45% in the SFM group and of 0.43% in the DM group ( P = .592). No statistically signifi cant differences were observed in cancer detection rates in the fi rst screening round between the SFM and DM groups (0.52% vs 0.53%, respectively; P = .862) or at successive screening rounds (0.40% and 0.40%, respectively; P = .834). The percentage of ductal carcinoma in situ tumors was higher in the DM
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Sala et al screening rounds, while the recall rates and rates of invasive tests were lower in the DM group. Results in the same direction were observed in our study, with no statistically signifi cant differences being observed in the cancer detection population-based breast cancer screening program (one round before and one after the implementation of digital technology) were compared and no significant differences were observed in the cancer detection rate between the two rate, and false-positive results, such as the screening round, patient age, and reading protocol characteristics. In a previous study performed in one of the programs included in the present study ( 9 ) , two screening rounds of a ( 17 ) , which was explained in part by the screening saturation effect and the decline in the use of hormone replacement therapy. The recall rate, false-positive results overall, and false-positive fi ndings resulting in an invasive procedure were found to be lower with DM than with SFM and remained lower after adjustment was made for women's age, women's screening mammogram, radiology unit screening round (programs started in different years), and the program to control for the variability introduced by differences in the programs' characteristics such as the number of views and the reading method. A reduction in the recall rate in the DM group was reported in one paired study ( 18 ) and by two studies performed in a daily-practice environment ( 8, 9 ) , while no differences in the recall rate were observed between the two modalities in two further studies performed in a daily-practice environment ( 3, 6 ) and in one paired study ( 15 ) . Although we could not control for radiologists' experience or some other conditions such as mammography viewing, the analysis controlling for period and technique suggested that the effects partly explained the differences observed in the results on the recall rate, as discussed elsewhere ( 1, 20 ) , and suggest that factors other than the mammographic technique may play a major role in the risk of recall and false-positive results. However, the real impact of DM needs to be understood for complete evaluation of the adverse effects of breast cancer screening.
False-positive rates after invasive procedures were lower with DM than with SFM. We found no studies comparing the results of invasive tests between the two modalities. Nevertheless, the adverse effect of a false-positive result after an invasive procedure is higher in terms of the physical impact to women and involves a higher cost than imaging procedures and a delay in informing women of the results.
One of the limitations of this study was the relatively short period for which there is experience with DM and that many factors that were not controlled may have infl uenced the quality and process indicators. For instance, PPV is affected by prevalence, which was not controlled for in the present study. However, we did control for some important factors such as time trends, women's screening mammogram, age at screening, and radiology unit screening round and included information from different breast cancer screening programs.
Although information about falsenegative results from women in the DM group is lacking, which hampered complete evaluation of the impact of the introduction of this technique, these results suggest that the introduction of DM, apart from its technical advantages, does not increase the adverse effects related to recall rate and false-positive results. On the contrary, reduction of the falsepositive rate could prevent a very large number of women from experiencing the consequences of this adverse effect.
